Hearing evaluation of patients with head and neck cancer: Comparison of Common Terminology Criteria for Adverse Events, Brock and Chang adverse event criteria in patients receiving cisplatin

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0347|37|8|1102-1107

ISSN： 1043-3074

Source： HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol.37, Iss.8, 2015-08, pp. : 1102-1107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Disclosing Adverse Events to Patients

By Cantor Michael D.   Barach Paul   Derse Arthur   Maklan Claire W.   Wlody Ginger Schafer   Fox Ellen  

Joint Commission Journal on Quality and Patient Safety, Vol. 31, Iss. 1, 2005-01 ,pp. : 5-12

Joint Commission Resources

Access to resources Recommend Favorite

Cardiovascular and pulmonary adverse events in patients treated with BCR‐ABL inhibitors: Data from the FDA Adverse Event Reporting System

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 4, 2015-04 ,pp. : E66-E72

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of Audiometry prior to High-Dose Cisplatin in Patients with Head and Neck Cancer

By  

Oncology, Vol. 93, Iss. 2, 2017-05 ,pp. : 75-82

Karger

Access to resources Recommend Favorite

Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 5, 2015-05 ,pp. : 798-806

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reporting of Sentinel Events in Swedish Hospitals: A Comparison of Severe Adverse Events Reported by Patients and Providers

By Öhrn Annica   Elfström Johan   Liedgren Christer   Rutberg Hans  

Joint Commission Journal on Quality and Patient Safety, Vol. 37, Iss. 11, 2011-11 ,pp. : 495-501

Joint Commission Resources

Access to resources Recommend Favorite